Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Ticker SymbolRDY
Company nameDr Reddy's Laboratories Ltd
IPO dateJan 01, 1986
CEOAghanian (Patrick)
Number of employees27811
Security typeDepository Receipt
Fiscal year-endJan 01
Address8-2-337, Road No.3 Banjara Hills
CityHYDERABAD
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryIndia
Postal code500-034
Phone914049002900
Websitehttps://www.drreddys.com/
Ticker SymbolRDY
IPO dateJan 01, 1986
CEOAghanian (Patrick)